EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

In vitro activity of isavuconazole, ravuconazole, and comparison of the Sensititre YeastOne and CLSI broth microdilution methods against clinical isolates of Trichosporon species

Shih-Hao Lo iD, Yi-Ting Tseng, Yee-Chun Chen, Mao-Wang Ho, Chen-Hsiang Lee, Po-Liang Lu, Shang-Yi Lin iD

Journal of Clinical Microbiology · 2025

DOI: 10.1128/jcm.00319-25 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Clinical Microbiology, 2025. Verfasst von Shih-Hao Lo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Antifungal Agents, Triazoles, Nitriles, Trichosporon. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hsinchu Science Park Bureau, Ministry of Science and Technology, Taiwan, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate the in vitro activity of isavuconazole and ravuconazole against clinical Trichosporon isolates. Additionally, we assessed the performance of the Sensititre YeastOne (SYO) assay compared to the reference Clinical and Laboratory Standards Institute (CLSI) broth microdilution (BMD) method for antifungal susceptibility testing. A total of 267 Trichosporon clinical isolates were collected from multiple centers in Taiwan between 2008 and 2020. The MIC values for amphotericin B, fluconazole, itraconazole, posaconazole, and voriconazole obtained using the CLSI BMD were compared to those determined using SYO. Among the seven antifungal agents tested using the CLSI BMD method, T. asahii isolates ( n = 224) exhibited significantly higher MICs for fluconazole, voriconazole, isavuconazole, and ravuconazole compared to non- T . asahii isolates ( n = 43) ( p < 0.05). Across all isolates, voriconazole demonstrated the lowest geometric mean (GM) MIC (0.06 mg/L). For T. asahii , the MIC₅₀, MIC₉₀, and GM MICs for posaconazole, isavuconazole, and ravuconazole were within ±1 twofold dilution, while mode MICs showed slightly greater variation (MIC₅₀, MIC₉₀, mode, and GM MICs were 0.25, 0.5, 0.5, and 0.28 mg/L; 0.12, 0.5, 0.12, and 0.17 mg/L; and 0.25, 0.5, 0.25, and 0.21 mg/L, respectively). The consistency of the MIC measurements between the SYO and CLSI BMD methods was assessed for amphotericin B, fluconazole, itraconazole, posaconazole, and voriconazole. The highest agreement within ±1 twofold dilution for T. asahii isolates was observed for posaconazole (94.2%). The essential agreement within ±2 twofold dilutions between both methods for all drugs was >97%. In conclusion, isavuconazole and ravuconazole demonstrated favorable in vitro activity against clinical Trichosporon isolates, while the SYO assay showed good concordance with the CLSI BMD method. IMPORTANCE Invasive infections caused by Trichosporon species pose significant therapeutic challenges, primarily due to their intrinsic resistance to echinocandins and the limited availability of effective treatment options. This study provides essential data on the in vitro activity of newer azoles and comprehensively evaluates the performance and concordance of the Sensititre YeastOne (SYO) and CLSI broth microdilution (BMD) methods. The current study analyzed 267 Trichosporon clinical isolates collected from multicenter settings in Taiwan. Our results demonstrate that both isavuconazole and ravuconazole exhibit favorable in vitro activities against Trichosporon species. For T. asahii , the essential agreement between the SYO and CLSI BMD methods exceeded 97% for all tested antifungal agents, indicating that the SYO method exhibits good concordance for most Trichosporon species. Further investigations are warranted to validate these findings and to assess their clinical implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsTriazolesNitrilesTrichosporonPyridinesMicrobial Sensitivity TestsHumansTaiwanTrichosporonosis

Stichwörter der Autor:innen

CLSISensititre YeastOneTrichosporonfluconazoleisavuconazoleminimal inhibitory concentrationravuconazolevoriconazole

Substanzen

Antifungal AgentsTriazolesisavuconazoleNitrilesPyridines

Autor:innen und Institutionen

  • Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.
  • Division of Infectious Diseases, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
  • Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Kaohsiung, Taiwan.
  • Department of post-baccalaureate Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

ORCID-Profile: Shih-Hao Lo, Shang-Yi Lin

Förderung

  • Hsinchu Science Park Bureau, Ministry of Science and Technology, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital
  • Kaohsiung Medical University

Zitieren

APA

Lo, S. H., Tseng, Y. T., Chen, Y. C., Ho, M. W., Lee, C. H., Lu, P. L., & Lin, S. Y. (2025). In vitro activity of isavuconazole, ravuconazole, and comparison of the Sensititre YeastOne and CLSI broth microdilution methods against clinical isolates of Trichosporon species. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00319-25

Vancouver

Lo SH, Tseng YT, Chen YC, Ho MW, Lee CH, Lu PL, et al. In vitro activity of isavuconazole, ravuconazole, and comparison of the Sensititre YeastOne and CLSI broth microdilution methods against clinical isolates of Trichosporon species. Journal of Clinical Microbiology. 2025. doi:10.1128/jcm.00319-25

BibTeX
@article{Lo2025,
  author = {Lo, Shih-Hao and Tseng, Yi-Ting and Chen, Yee-Chun and Ho, Mao-Wang and Lee, Chen-Hsiang and Lu, Po-Liang and Lin, Shang-Yi},
  title = {In vitro activity of isavuconazole, ravuconazole, and comparison of the Sensititre YeastOne and CLSI broth microdilution methods against clinical isolates of Trichosporon species},
  journal = {Journal of Clinical Microbiology},
  year = {2025},
  doi = {10.1128/jcm.00319-25}
}
Kostenlos starten →